Seeking Alpha

Shares of Danish pharma Novo Nordisk (NVO +5.8%) surge after it announces FDA approval of its...

Shares of Danish pharma Novo Nordisk (NVO +5.8%) surge after it announces FDA approval of its Levemir drug for pregnant women with diabetes after finding it did not increase the risk to unborn babies. NVO says it's now "the only company that offers a complete portfolio of insulin analogs" with this approval.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs